Institut Paoli-Calmettes: Neoplasms trials

The registry lists 12 Neoplasms studies with Institut Paoli-Calmettes as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUMNot yet recruitingNCT06066255Phase 2
• Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine TumorsRecruitingNCT04520932Not applicable
• Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 YearsRecruitingNCT03463668
• Institut Paoli-Calmettes Pancreatic Neoplasms DatabaseRecruitingNCT02869581
• "Patient Autonomie" in People With CancerStatus unknownNCT04517773
• Database for Data Collection in the Context of an Enhanced Recovery After Surgery Program in Oncology SurgeryStatus unknownNCT03950011
• Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic ShockCompletedNCT03683329Phase 3
• Nomogram Control of Predictive Factors of Early Withdrawal After Gynecologic Oncology Surgery in the Enhanced Recovery After Surgery (ERAS) Protocol and Assessment of PracticesStatus unknownNCT03470870
• Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic IndicationsCompletedNCT02865889
• Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
• Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmCompletedNCT00908869Phase 1
• Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2